Nasdaq® Dividend Achievers 25 Portfolio, Series 11
Ticker Symbol: FDAERX
||Cardinal Health, Inc.
||The Clorox Company
||CVS Health Corporation
||Eaton Vance Corp.
||The Gap, Inc.
||International Business Machines Corporation
||Johnson & Johnson
||Lockheed Martin Corporation
||NextEra Energy, Inc.
||Southside Bancshares, Inc.
||Southwest Gas Holdings, Inc.
||Texas Instruments Incorporated
||United Technologies Corporation
||Walgreens Boots Alliance, Inc.
* As of the close of business on 1/2/18.
Market values are for reference only and are not indicative of your individual
|Not FDIC Insured Not Bank Guaranteed May Lose Value
|Initial Date of Deposit
|Initial Public Offering Price
||$10.00 per Unit
| Portfolio Ending Date
|Estimated Net First Year Distribution per Unit*
|Estimated Net Subsequent Year Distribution per Unit*
|Fee Accounts Cash CUSIP
|Fee Accounts Reinvestment CUSIP
*The estimates are based on annualizing the most
recent dividends declared by the issuers of the
securities included in the portfolio. The estimated net
annual distribution for the subsequent year is expected
to be less than the amount for the first year because a
portion of the securities included in the portfolio will be
sold during the first year to pay for organization costs,
the deferred sales charge and the creation and
development fee. There is no guarantee that the issuers
of the securities included in the portfolio will declare
dividends in the future or that, if declared, they will
remain at current levels or increase over time.
|Sales Charges (based on a $10 public offering
|Transactional Sales Charges:
|Creation & Development Fee:
|Maximum Sales Charge:
The deferred sales charge will be deducted in three monthly installments commencing 4/20/18.
When the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If
the price exceeds $10.00 per unit, you will pay an initial sales charge.
|Maximum Sales Charge:
The maximum sales charge for investors in fee accounts consists of the creation and development fee.
Investors in fee accounts are not assessed any transactional sales charges. Standard accounts sales charges
apply to units purchased as an ineligible asset.
The creation and development fee is a charge of $.050 per unit collected at
the end of the initial offering period. If the price you pay exceeds $10 per
unit, the creation and development fee will be less than 0.50%; if the price
you pay is less than $10 per unit, the creation and development fee will exceed
In addition to the sales charges listed, UITs are subject to annual operating expenses and organization costs.
You should consider the portfolio's investment objective, risks, and
charges and expenses carefully before investing. Contact your financial advisor
or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus,
which contains this and other information about the portfolio. Read it carefully
before you invest.
Nasdaq® and NASDAQ US Broad Dividend Achievers IndexTM are registered trademarks of Nasdaq, Inc.
(which with its affiliates are the Corporations) and are licensed for use by First Trust Portfolios L.P. The
portfolio has not been passed on by the Corporations as to its legality or suitability. The portfolio is not
issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES
AND BEAR NO LIABILITY WITH RESPECT TO THE PORTFOLIO.
An investment in this unmanaged unit investment trust should be made with an understanding of the risks involved with owning common stocks, such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market.
You should be aware that the portfolio is concentrated in stocks in the consumer products sector
which involves additional risks, including limited diversification. The companies engaged in the
consumer products industry are subject to global competition, changing government
regulations and trade policies, currency fluctuations, and the financial and political risks
inherent in producing products for foreign markets.
An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as the share prices of small-cap companies and
certain mid-cap companies are often more volatile than those of larger companies due to several factors, including limited trading volumes, products,
financial resources, management inexperience and less publicly available information.
An investment in a portfolio containing equity securities of foreign issuers is subject to
additional risks, including currency fluctuations, political risks, withholding, the lack of
adequate financial information, and exchange control restrictions impacting foreign issuers.
This UIT is a buy and hold strategy and investors should consider their ability
to hold the trust until maturity. There may be tax consequences unless units
are purchased in an IRA or other qualified plan.
The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.